Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2720
-0.0010 (-0.37%)
Jun 23, 2026, 2:02 PM EDT - Market open

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $961.00K in the quarter ending March 31, 2026, a decrease of -27.18%. This brings the company's revenue in the last twelve months to $4.71M, down -24.36% year-over-year. In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%.

Revenue (ttm)
$4.71M
Revenue Growth
-24.36%
P/S Ratio
0.85
Revenue / Employee
$470,788
Employees
10
Market Cap
4.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bio Green Med Solution1.53M
60 Degrees Pharmaceuticals1.31M
SciSparc856.00K
GeoVax Labs852.28K
Azitra7.50K
Revenue Rankings